Cvek 1992 - Luxated Nonvital Incisors Apexification
Citation and study context
Cvek M. Prognosis of luxated non-vital maxillary incisors treated with calcium hydroxide and filled with gutta-percha. A retrospective study. Endod Dent Traumatol 1992;8:45-55.1
Evidence type: Retrospective clinical study, as identified by the L16 article-title crop.
The cited population is luxated non-vital maxillary incisors treated with calcium hydroxide and filled with gutta-percha. L16’s typed citation says “A retrospective study”; the article-title crop on PDF page 7 says “A retrospective clinical study.” Both source forms are retained. The title crop and fracture table appear together on page 7.2
Fracture distribution by root-development stage
L16 attributes this stage-stratified table to Cvek:
| Stage of root development | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| Number of teeth | 26 | 71 | 106 | 194 | 362 |
| Number of fractures | 20 | 38 | 46 | 55 | 9 |
| Per cent | 77 | 53 | 43 | 28 | 2 |
Stages 1-4 are immature; stage 5 is mature. The table reports the highest fracture proportion at stage 1 and the lowest at stage 5. L16 gives no further study methods, outcome-assessment detail, or follow-up duration in this evidence block.
Related lecture context
L17 lists Cvek alongside Andreasen et al. beneath its claim that long-term calcium hydroxide root-canal dressing carries higher fracture risk; the lecture does not separate each paper’s contribution.3
L16’s local teaching on thin dentinal walls and cervical fracture risk remains in L16 Management of Incompletely Developed Tooth 1 > Thin Dentinal Walls and Cervical Fracture Risk. The L17 context is in L17 Management of Incompletely Developed Tooth 2 > Shortcomings Of Calcium Hydroxide Apexification.
Original lecture pages
Takeaway
In the retrospective study of luxated non-vital maxillary incisors treated with calcium hydroxide and gutta-percha, the L16 Cvek-attributed table reports fracture proportions from 77% at stage 1 to 2% at stage 5; the lecture excerpt provides no further protocol or follow-up detail.